New injection aims to ease bone cancer pain
NCT ID NCT06380881
First seen Nov 18, 2025 · Last updated May 14, 2026 · Updated 22 times
Summary
This early-phase study tested an experimental drug called SHR-2017 in 25 adults with solid tumors that spread to the bone. The main goals were to see how the drug moves through the body, how safe it is, and whether it helps reduce bone pain and prevent bone-related events like fractures. Participants had significant pain despite stable pain medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATIENTS WITH BONE METASTASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, 100142, China
Conditions
Explore the condition pages connected to this study.